Side Effect of Preoperative Neoadjuvant Chemotherapy on Lung Cancer Patients and the Progress of Anesthesia Management

KAN Hongli,SUN Hong,GUAN Jian,LI Ming,ZHOU Jianying,ZHUANG Yingying,MA Haichun
DOI: https://doi.org/10.3969/j.issn.1674-4721.2013.01.012
2013-01-01
Abstract:Now, lung cancer becomes the first death cause of malignant tumors. Non-small cell lung cancer operation is one treatment option, but only 20% of the patients have the opportunity of operation treatment. With the development of medical technology is developing rapidly, people on the treatment for non-small cell lung cancer have new study. Introducing the preoperative induced chemotherapy (neoadjuvant chemotherapy) is a concept, so that patients receive a chance of operation resection of the tumor. Preoperative chemotherapy has a lot of advantages, but its adverse reaction can not be ignored, chemotherapy drugs have more toxicity to liver, kidney function influence also to lung, heart, nerve and blood. Therefore, lung cancer treatment update require anesthesia techniques to further more. This review on the anesthetic management which include anesthesia evaluation and guidance, tracheal catheter selection and all management at pre- or post-operative of patients after chemotherapy with lung cancer and other aspects of progress to make introduction.
What problem does this paper attempt to address?